Lument Finance Trust, Inc. 8-K

What Happened

• Lument Finance Trust, Inc. announced that on July 24, 2026 it received a notice from the New York Stock Exchange that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the company's average closing price fell below $1.00 over a consecutive 30 trading‑day period.
• The notice is a deficiency notice (not a delisting order); the company’s common stock remains listed and tradable while it has a six‑month cure period to regain compliance. The company issued a press release on July 30, 2026 announcing the notice.

Key Details

• Date of notice: July 24, 2026; press release issued July 30, 2026.
• NYSE rule cited: Section 802.01C — 30 trading‑day average closing price below $1.00.
• Cure period: six months from receipt; the company can regain compliance if, on the last trading day of any calendar month during the cure period, the closing share price is at least $1.00 and the 30 trading‑day average is at least $1.00.
• The company is monitoring its stock price and is considering alternatives (including a possible reverse stock split), but has made no commitments.

Why It Matters

• For investors, this is a material corporate governance/listing issue: if Lument fails to meet the NYSE minimum price requirement within the cure period, it could face delisting, which typically reduces liquidity and can negatively affect share value.
• For now, trading continues normally on the NYSE, but investors should watch the stock price, company updates, and any corporate actions (such as a reverse stock split) that could affect shares outstanding and per‑share price.